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Eating disorder is a group of physiological and psychological disorders affecting approximately 1% of the female population 
worldwide. Although the genetic epidemiology of eating disorder is becoming increasingly clear with accumulated studies, the 
underlying molecular mechanisms are still unclear. Recently, integration of various high-throughput data expanded the range 
of candidate genes and started to generate hypotheses for understanding potential pathogenesis in complex diseases. This arti-
cle presents EDdb (Eating Disorder database), the first evidence-based gene resource for eating disorder. Fifty-nine experi-
mentally validated genes from the literature in relation to eating disorder were collected as the core dataset. Another four da-
tasets with 2824 candidate genes across 601 genome regions were expanded based on the core dataset using different criteria 
(e.g., protein-protein interactions, shared cytobands, and related complex diseases). Based on human protein-protein interaction 
data, we reconstructed a potential molecular sub-network related to eating disorder. Furthermore, with an integrative pathway 
enrichment analysis of genes in EDdb, we identified an extended adipocytokine signaling pathway in eating disorder. Three 
genes in EDdb (ADIPO (adiponectin), TNF (tumor necrosis factor) and NR3C1 (nuclear receptor subfamily 3, group C, mem-
ber 1)) link the KEGG (Kyoto Encyclopedia of Genes and Genomes) “adipocytokine signaling pathway” with the BioCarta 
“visceral fat deposits and the metabolic syndrome” pathway to form a joint pathway. In total, the joint pathway contains 43 
genes, among which 39 genes are related to eating disorder. As the first comprehensive gene resource for eating disorder, 
EDdb (http://eddb.cbi.pku.edu.cn) enables the exploration of gene-disease relationships and cross-talk mechanisms between 
related disorders. Through pathway statistical studies, we revealed that abnormal body weight caused by eating disorder and 
obesity may both be related to dysregulation of the novel joint pathway of adipocytokine signaling. In addition, this joint 
pathway may be the common pathway for body weight regulation in complex human diseases related to unhealthy lifestyle.  
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Eating disorder (MeSH D001068) is a group of physiologi-
cal and psychological disorders defined by abnormal diet 
behavior. It mainly consists of several diagnoses: anorexia 
nervosa (AN), bulimia nervosa (BN), binge eating disorder 
(BED) and eating disorder not otherwise specified (EDNOS) 
[1,2]. Besides their disturbances in appetite and food intake, 
the irrational attitude towards weight and body shape may 
cause suicidal thinking. Interestingly, women are affected 
10 times more frequently than men [3]. It has been estimat-
ed that nine in 1000 women in the USA are affected by an-
orexia nervosa [4]. However, current genetic predisposition 
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information is scattered in the published literature. Only 12 
genes with positive evidence are stored in GAD (Genetic 
Association Database) [5]. A more comprehensive gene 
resource needs to be developed to acquire a more complete 
picture of eating disorder.  
Common unhealthy lifestyles, such as smoking, can in-
crease the risk of several metabolic disorders including eat-
ing disorder, hypertension, obesity, type 2 diabetes mellitus 
and ischemic heart disease [6–9]. In particular, the symp-
toms of eating disorder often overlap with other weight- 
related disorders such as obesity because of common un-
healthy diets [1016]. Although the cause of obesity and 
eating disorder is becoming increasingly clearer with 
large-scale and individual genetic studies, the common mo-
lecular pathway underlying abnormal body weight between 
these two weight-related disorders has not been analysed 
yet. 
Although genome-wide association studies have revealed 
a number of loci in complex diseases such as obesity 
[17,18], two high-throughput studies on eating disorder 
were unsuccessful in revealing more loci. One study was 
designed to scan genomic regions of 182 genes from the 
literature, but resulted in no significant SNPs (single-   
nucleotide polymorphisms) for anorexia nervosa [19]. The 
other genome-wide association study on anorexia nervosa 
sampled 4766 individuals, but confirmed only one common 
SNP within OPRD1 (Opioid Receptor, Delta 1) [3].  
Systematic and statistical analysis of genes and their 
pathways may provide a more complete pathway related to 
the molecular mechanism underlying eating disorder. The 
majority of identified genes related to eating disorder can be 
classified into two groups, which are relevant to the neuro-
transmitter system and body weight regulation. For neuro-
transmitters, several systems have been proposed, such as 
the serotonergic system, noradrenergic system and dopa-
minergic system, while genes for weight regulation are 
mainly associated with the leptinergic-melanocortinergic 
system [20]. The association of the molecular mechanisms 
of these systems with other relevant diseases remains to be 
explored.  
In this article, we developed an eating disorder gene da-
tabase, EDdb (Eating Disorder database), for cataloguing 
genes linked to this disorder. Our data representing genetic 
knowledge encompasses a collection of all types of evi-
dence including mutation analysis, gene expression, gene 
association, family-based linkage studies, genome-wide 
association studies and other functional studies. The focus 
of this resource is to provide an up-to-date and annotated 
list of eating disorder candidate genes to serve as reference 
datasets for understanding its etiology. In addition, we set 
up a strategy for unveiling novel eating disorder susceptibil-
ity genes by protein-protein interactions, shared cytobands 
or related diseases such as obesity. Based on integrated 
protein-protein interaction data, we have reconstructed a  
potential network closely related to eating disorder. Fur-
thermore, our systematic and statistical pathway studies 
revealed that the abnormal body weight caused by eating 
disorder may be caused by dysregulation of important sig-
naling events occurring in a joint pathway combining the 
KEGG (Kyoto Encyclopedia of Genes and Genomes) “adi-
pocytokine signaling pathway” and the BioCarta “visceral 
fat deposits and the metabolic syndrome” pathway.  
1  Materials and methods 
1.1  Data collection and automation of gene annotation 
The genes related to eating disorder in the core dataset were 
extracted from 567 abstracts from the year 2010, retrieved 
by PubMed query ‘((anorexia nervosa) OR (bulimia nervosa) 
OR (eating disorder)) AND gene’. The data spanned multi-
ple technology platforms including single-gene mutation 
analysis, family-based linkage studies, population associa-
tion studies, gene expression analysis, genome-wide associ-
ation studies and other functional analyses. Seven raw da-
tasets were prepared for the gene list expansion. The first 
raw dataset included four controversial genes (DRD3, TNF, 
UCP2 and UCP3) with equally positive and negative evi-
dence from individual articles. Another literature dataset 
was collected from the supplement of Pinheiro et al. [19]. In 
addition, three datasets of related diseases (obesity, bipolar 
disorder and schizophrenia) were collected from Gene As-
sociation Database [5]. For accuracy, we excluded negative 
records of the three disorders in Gene Association Database. 
The protein-protein interaction partners of genes in the core 
dataset were integrated from the BioGRID (September 25, 
2011 Version 3.1.81) [21], HPRD (April 13, 2010 Version 9) 
[22], and BIND (downloaded on December 15, 2009) [23] 
databases. Finally, the last raw dataset contained genes that 
shared cytobands with genes from the core dataset [24]. 
The core dataset will be routinely updated based on 
newly published literature. In addition to continuous data 
curation and integration of literature and other disease re-
lated databases, we will focus on constructing regulatory 
networks in humans with emphasis on their regulatory tran-
scription factors and phosphorylation. An automatic annota-
tion pipeline was implemented to integrate functional in-
formation about the genes from the Entrez gene database 
(January 13, 2011) [24], Gene Ontology annotation, inter-
acting proteins from HPRD/BIND/BioGRID, and OMIM 
annotation using Perl script and Swiss knife module 
[22,25–27]. Signaling event annotation was added to each 
gene according to the KEGG LIGAND and BioCarta data-
bases [28,29]. With the automatic pipeline for data annota-
tion, our database can be easily updated when new versions 
of external databases such as BioCarta and KEGG LIGAND 
are available.  
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1.2  Sub-network extraction 
To obtain a network of eating disorder genes, we firstly 
constructed a non-redundant human interactome based on 
the protein-protein interaction data from the HPRD, IntAct, 
BioGRID and MINT databases. In addition, we excluded 
self-interactions, interactions predicted by computational 
methods, and interactions with other species for five net-
works. The final interactome contained 12363 nodes and 
70019 protein-protein interaction links. The degree of all 
nodes in this human PPI network followed the power law 
distribution, P(k)~kb, where P(k) represents the probability 
that a node interacts with k nodes and b is an exponent with 
an estimated value of 1.683. This indicated that most genes 
in this human PPI network were sparsely connected, while a 
small part of them had relatively high connectivity. Using 
the Steiner minimal tree algorithm [30], we extracted the 
sub-network as an eating disorder-specific network from the 
whole human interactome. In our implemented algorithm, 
the sub-network was first constructed with all input genes in 
the core dataset connected. Finally, a minimum net with 
input genes connected by shortest path was produced. 
1.3  Web interface construction 
All data and information in EDdb are stored in a MySQL 
relational database on a Linux server [31–33]. The database 
provides a web interface, which allows researchers to 
browse candidate genes from different features. Web-based 
queries to the database were implemented in Perl scripts 
running in an Apache environment. EDdb allows users to do 
text query, or to run BLAST searches against the sequences 
in EDdb. For an advanced study, this database provides all 
nucleotide and protein sequences in a FASTA format for all 
the entries. Furthermore, cross-references to external data-
bases such as KEGG and iHOP (information hyperlinked 
over proteins) are included for each record in EDdb. In ad-
dition, for each gene in the core dataset, links to the original 
articles related to eating disorder in the NCBI PubMed da-
tabase are given (Figure 1). 
1.4  Identification of representative pathways using 
KOBAS 
Throughout the paper, the representative pathways from the  
KEGG and BioCarta databases for each gene set were iden-
tified by KOBAS (KEGG Orthology Based Annotation 
System) [34]. In these pathway analyses, all human protein- 
coding genes in KOBAS were set as the background to cal-
culate statistical significance. In addition, the false discov-
ery rate (FDR)-corrected P-values for enriched pathways 
were adopted based on the hypergeometric test. Finally, the 
enriched human pathways with corrected P-values of less 
than 0.01 were identified as over-representative pathways 
for each gene set. 
1.5  Empirical resampling for evaluating the relation-
ships between eating disorder and other diseases 
To determine whether eating disorder is related to obesity, 
schizophrenia and bipolar disorder more than expected, we 
conducted a total of 1000 resamplings. Here, we took the 
obesity gene for example. During each process, 59 human 
genes were randomly selected from 45522 human genes in 
the Entrez gene database (January 13, 2011). We repeated 
this random process 1000 times.  
Next, we counted the number of randomly selected node 
sets (N) whose number of overlapping genes was more than 
the actual number of overlapping genes [33]. Finally, we  
 
 
Figure 1  Web interface of EDdb. A, Query interface for text search. B, Data browser by chromosomes. C, The related literature contents in each confirmed 
gene page. D, Blast interface for sequence search against all genes in EDdb. 
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calculated the empirical P-value using N/1000 to represent 
the significance of how the 59 eating disorder genes are 
related to obesity in gene content. Next, we applied a simi-
lar approach to schizophrenia and bipolar disorder. Based 
on this empirical resampling approach, the empirical 
P-values for the relationship between the eating disorder 
gene set and obesity, schizophrenia and bipolar disorder are 
all less than 0.01. 
2  Results 
As the first literature-based data resource for eating disorder, 
our database provides clearer clues for classifying this dis-
ease and reveals an underlying biological pathway model 
from a genetic view. 
2.1  Collection of the core dataset, consisting of experi-
mentally verified candidate genes for eating disorder 
As shown in Figure 2, the comprehensive collection of ex-
perimentally verified genes in EDdb was accomplished by 
curating published literature in the following four steps: (i) 
An extensive literature search was conducted through Pub-
Med with the keywords “eating disorder”, “anorexia nervo-
sa”, “bulimia nervosa” or “binge eating disorder” (see Ma-
terials and methods); (ii) the retrieved abstracts were high-
lighted with query keywords and grouped by the Related 
Articles function in Entrez; (iii) the abstracts were manually 
read to list the experimentally verified candidate genes for 
eating disorder and other related information such as ex-
perimental methods and populations; (iv) the candidate gene 
names were manually mapped to Entrez Gene ID and auto-
matic annotation was performed (see Materials and meth-
ods). We also recorded negative results for each gene, and 
we assumed that genes with more positive reports were 
candidate genes. Only four genes (DRD3 (Dopamine Re-
ceptor D3), TNF (tumor necrosis factor), UCP2 (uncoupling 
protein 2) and UCP3 (uncoupling protein 3)) with equal 
negative and positive reports were excluded from the core 
dataset. Finally, 59 confirmed genes related to eating disor-
der were stored in this core dataset, including three overlap- 
ping subsets: 52 genes related to anorexia nervosa, 19 genes 
related to bulimia nervosa, and 25 genes related to eating 
disorder. Among these 59 genes, 33, 31 and 20 were related 
to obesity, schizophrenia and bipolar disorder, respectively. 
Further empirical re-sampling demonstrated that eating dis-
order was closely related to obesity, schizophrenia and bi-
polar disorder in genetics, which were all significantly re-
lated to the 59 genes related to eating disorder (see section 
4.5).  
So far gene-set enrichment analysis is probably the most 
practical and successful data mining approach for address-
ing the challenge of analyzing complex gene lists [35]. Here, 
we employed KEGG and BioCarta pathway enrichment 
analysis to summarize the possible signaling mechanisms of 
eating disorder. As listed in Table 1, the top 10 enriched 
pathways were mostly related to endocrine and nervous 
system signaling pathways, amino acid metabolism as well 
as fat deposit and metabolism. The statistical enrichments of 
amino acid metabolism could be explained by the MAOA 
(monoamine oxidase A) and MAOB (monoamine oxidase B) 
genes, which are involved in the metabolism of several 
amino acids tyrosine, tryptophan, phenylalanine and histi-
dine. Because of their vital roles in the inactivation of neu-
rotransmitters, both genes were thought to be related to 
neural disorders such as Parkinson’s disease [36,37]. 
2.2  Expanding candidate genes by protein-protein in-
teractions and related diseases 
The above mentioned systematic collection had limited 
success in discovering confirmed causal genes of eating 
disorder. Earlier studies showed that protein-protein interac-
tion network, gene co-expression network and pathway en-
richment analysis may provide a practical approach to ex-
pand the gene list and unveil the underlying molecular 
mechanisms [38]. We therefore set up a pathway discovery 
strategy to expand signaling mechanisms behind eating dis-
order combining protein-protein interactions, gene cyto-
bands and related diseases. Seven raw datasets were pre-
pared for the gene list expansion, including two datasets 
from the literature (see Materials and methods), three relat-
ed disease (obesity, bipolar disorder and schizophrenia) 
datasets from Gene Association Database [5], one interac- 
tion dataset (genes interacting with genes from the core da-
taset) and one cytoband dataset (genes sharing cytobands 
with genes from the core dataset). First, we added 107 genes 
(hereafter referred to as EXP1 dataset) from the two litera-
ture datasets as they were also present in the other five re-
lated raw datasets. Next, for the second expansion (hereafter 
referred to as EXP2 dataset) 148 genes were added from the 
three disease datasets, as they also had support from the 
interaction and cytoband datasets. With more than two di-
rect functional confirmations, the 255 genes from the EXP1 
and EXP2 datasets were convincingly important in the 
pathogenesis of eating disorder, making them very good 
candidates for further functional investigations. The third 
expansion was 793 genes (hereafter referred to as EXP3 
dataset) with evidence from only three disease datasets. The 
last one was 1775 genes (hereafter referred to as EXP4 da-
taset) with support only from the protein interaction dataset.  
Once the extension of candidate genes was achieved, a 
subsequent interpretation task was required to evaluate the 
biological roles of the expanded genes. Because most of the 
genes play a wide variety of roles in different cellular func-
tions, great caution was taken to avoid introducing non- 
specific pathways to data interpretation. Our pathway con-
text analysis was conducted using a hypergeometric statis-
tical comparison. Each expansion was involved in several   
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Figure 2  Pipeline for collection, expansion and annotation of genes related to eating disorder. 
Table 1  Top 10 significantly enriched signaling pathways of 59 genes in the core dataset from the KEGG and BioCarta databasesa) 
Pathway Source P-value* 
Neuroactive ligand-receptor interaction KEGG 3.98×10 
Adipocytokine signaling pathway KEGG 6.63×10 
Reversal of insulin resistance by leptin BioCarta 5.52×10 
Metabolism of anandamide, an endogenous cannabinoid BioCarta 7.69×10 
Visceral fat deposits and the metabolic syndrome BioCarta 1.02×10 
Tyrosine metabolism KEGG 2.22×10 
Tryptophan metabolism KEGG 2.39×10 
Phenylalanine metabolism KEGG 6.29×10 
Neurotrophin signaling pathway KEGG 1.04×10 
Histidine metabolism KEGG 1.59×10 
a) *, Corrected by Benjamin-Hochberg. 
signaling pathways, including the calcium signaling path-
way, long-term depression, Gap Junction and PPAR (pe-
roxisome proliferator-activated receptor) signaling pathway 
(Table S1 in Supporting Information). Some of these path-
ways, e.g., Gap Junction and long-term depression, should 
perhaps be considered as generic rather than specific path-
way, indicating the presence of general processes in neural 
disorders. Interestingly, only neuroactive ligand-receptor 
interaction and the adipocytokine signaling pathway were 
always present in the top 10 pathways in the different da-
tasets. They are intuitively linked with eating disorder, be-
cause of their close relationships with neural activity. 
However, in the KEGG pathway, the neuroactive lig-
and-receptor interaction was only a list of interaction pairs 
between neuroactive signaling molecules and their receptors 
instead of a fully connected map. Thus, it was very difficult 
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to achieve a connected molecular network. On the contrary, 
the adipocytokine signaling pathway is a fully connected 
graph. More interestingly, adipocytokines such as leptin and 
adiponectin are important signaling molecules involved in 
neuronal circuits for food intake and are related to obesity, 
insulin resistance and cancer [39–44].  
2.3  Identifying representative genes in the adipocyto-
kine signaling pathway related to eating disorder  
Although leptin and adiponectin in the adipocytokine sig-
naling pathway are related to anorexia nervosa and bulimia 
nervosa [45,46], other downstream signaling circuits have 
not been reported to be related to eating disorder. Based on 
our gene collection, most of the genes in the adipocytokine 
signaling pathway are related to eating disorder (Figure 3). 
Six genes in the core dataset, including LEP (leptin), 
LEPR (leptin receptor), ADIPO (adiponectin), POMC 
(proopio- melanocortin), AGRP (agouti related protein 
homolog) and NPY (neuropeptide Y), were annotated to the 
adipocytokine signaling pathway. LEP, LEPR and ADIPO 
are the most important upstream signals for food intake 
[42,47]. The remaining three genes, POMC, AGRP and NPY, 
also play important roles in downstream signals in weight 
regulation or food intake [48–51]. Because of equally nega-
tive and positive reports, TNF (tumor necrosis factor) was 
not included in the core dataset, but only in the EXP1 da-
taset. TNF interferes with the early steps of insulin signaling 
[52,53]. Moreover, three genes including SOCS3 (suppres-
sor of cytokine signaling 3), PPARGC1A (peroxisome pro-
liferator-activated receptor gamma, coactivator 1 alpha) and 
ACC2 (acetyl-CoA carboxylase beta) were included in the 
EXP1 dataset. Both PPARGC1A and ACC2 are involved in 
the regulation of fatty acid oxidation [54,55]. Though 
SOCS3 cannot directly influence fatty acid oxidation, it in-
hibits leptin activation of AMPK (5′ AMP-activated protein 
kinase) [56]. In summary, 10 genes from the core dataset 
and the EXP1 dataset can be clustered into two categories: 
(i) four upstream signals including TNF, LEP, LEPR and 
ADIPO, which are related to obesity; (ii) six downstream 
effector molecules of metabolic regulation, among which 
five were also related to obesity. As genes from both the 
core dataset and the EXP1 dataset are shown to be involved 
in eating disorder, our next task was to fill in the gap be-
tween highly convincing upstream signals and downstream 
effector genes with data from protein-protein interactions 
and related disease studies. 
As shown in Figure 3, five genes from EXP2 are colored 
in the map. Three of them are receptors for ADIPO and TNF. 
The remaining two genes, STAT3 (signal transducer and  
 
 
Figure 3  Key signaling map for body weight regulation in eating disorder combined from “visceral fat deposits and the metabolic syndrome” and “adipo-
cytokine signalling pathway”. The genes from different datasets are color-coded. The color schemas for the different datasets are shown at the bottom of the 
map. 
1092 Zhao M, et al.   Sci China Life Sci   December (2013) Vol.56 No.12 
activator of transcription 3) and RXR (retinoid X receptor, 
alpha), are intermediate regulators in the adipocytokine 
signaling pathway. Furthermore, 10 genes from EXP3 and 
eight genes from EXP4 were introduced into the adipocyto-
kine signaling pathway. Finally, all the gaps between up-
stream signals and downstream molecules were filled in the 
map with only four genes (MTOR (mechanistic target of 
rapamycin), JNK (c-Jun N-terminal kinase), IKK (IB ki-
nase) and PRKCQ (Protein Kinase C, Theta)), which were 
not included in EDdb. Combining the four expansion da-
tasets, we identified 33 genes in the adipocytokine signaling 
pathway, among which 20, 13 and 4 were associated with 
obesity, schizophrenia and bipolar disorder, respectively. In 
particular, the high proportion of obesity related genes in the 
adipocytokine signaling pathway may provide clues for 
explaining weight regulation in both diseases. 
2.4  Key joint signaling map for eating disorder com-
bined from the “adipocytokine signaling pathway” and 
“visceral fat deposits and the metabolic syndrome” 
Different pathway databases have various pathway concepts 
[31,57]. The real cellular communications are dynamic and 
have no artificial boundaries. Connecting and combining 
common pathways from different databases through their 
cross-talking molecules is a direct approach to extend 
pathway paradigms. Our in-depth analysis of the top 10 
statistically representative pathways in Table 1 revealed that 
the “reversal of insulin resistance by leptin” pathway from 
BioCarta is a complete subset of the “adipocytokine signal-
ing pathway” from KEGG. Meanwhile, the “visceral fat 
deposits and the metabolic syndrome” pathway from Bio-
Carta and the “adipocytokine signaling pathway” from 
KEGG can be combined together to form a fully connected 
map. “Visceral fat deposits and the metabolic syndrome” 
pathway contains eight molecules, among which three 
downstream or mid-stream genes (ADIPO, TNF and RXR) 
are the same upstream or mid-stream molecules found in the 
“adipocytokine signaling pathway”. The remaining five  
Upstream molecules include PPARG (peroxisome prolifer- 
atoractivated receptor gamma), HSD11B2 (hydroxysteroid 
11-beta dehydrogenase 1), NR3C1 (nuclear receptor sub-
family 3, group C, member 1), LPL (lipoprotein lipase) and 
REST (resistin), among which REST and NR3C1 have been 
confirmed to be related to eating disorder [5860]. In addi-
tion, PPARG and LPL are both from the KEGG “PPAR 
signaling pathway”. Furthermore, at least five genes in Fig-
ure 3, including LPL, PEPCK (phosphoenolpyruvate car-
boxykinase), CPT1A (carnitine palmitoyltransferase 1A), 
FACS (acsl1 acyl-CoA synthetase long-chain family mem-
ber 1) and FAT/CD36 (fatty acid translocase/cluster of dif-
ferentiation 36), are regulatory targets of PPARG/RXR, 
PPARD/RXR and PPARA/RXR. Thus, these genes form a 
highly linked regulatory module, bridging the “PPAR sig-
naling pathway” and the “adipocytokine signaling pathway”, 
hence highlighting the potential roles of these genes in the 
pathogenesis of eating disorder. In summary, 43 genes, 
mainly from the “visceral fat deposits and the metabolic 
syndrome” pathway and the “adipocytokine signaling 
pathway” are interlinked through regulatory relationships 
between ADIPO, TNF and NR3C1. Other genes in our da- 
tabase, such as GSK3B (glycogen synthase kinase 3 beta), 
from other relevant signaling pathways could also be con-
nected to our summarized key joint signaling map (Figure 
3). More importantly, 39 among the 43 genes are stored in 
our EDdb, and 25 of them are associated with obesity.  
We observed a few more regulatory modules in the 
summarized key signaling map (Figure 3), for instance, the 
upstream regulatory module consisting of ADIPO, PPARG/ 
RXR, HSD11B2 and NR3C1, and another regulatory module, 
which is centered around LEPR, SOCS3 and JAK (Janus 
kinase). Cooperation of these coupled loops may transmit 
upstream signals to downstream cellular systems in fast or 
slow manners. Overall, our integration of several pathways 
from the BioCarta and KEGG databases revealed that eating 
disorder is a complex process caused by dysregulation of 
multiple highly interconnected pathways. 
2.5  Reconstruction of a core pathway for eating disor-
der genes using sub-network extraction from pro-
tein-protein interaction data 
The integrative pathway analysis above gave us a clue on 
how to reconstruct a core pathway for eating disorder. Here 
to reconstruct a potential biological process based on known 
protein-protein interactions in our EDdb, we firstly adopted 
a sub-network extraction approach. To get a comprehensive 
picture of eating disorder, we pieced together the pro-
tein-protein interaction data from the HPRD (Human Pro-
tein Reference Database), IntAct, BioGRID (Biological 
General Repository for Interaction Datasets) and MINT 
(Molecular INTeraction) databases. Based on 59 genes in 
our core dataset as seed, we used the Klein-Ravi algorithm 
to extract a sub-network from the integrated human pro-
tein-protein interaction (PPI) network (see Materials and 
methods). The final sub-network contains 78 genes in total 
(Figure 4). Fifty-three genes were in our eating disorder core 
dataset and the remaining 25 genes were linked to the 53 
genes, forming a fully connected network. Functional en-
richment analysis showed that the 78 genes in our recon-
structed sub-network were enriched in six pathways (Table 
2). The pathways “neuroactive ligand-receptor interaction”, 
“adipocytokine signaling pathway” and “visceral fat depos-
its and the metabolic syndrome” were the same as the en-
riched pathways in Table 1. The related pathways of three 
neurotransmitters including “serotonergic synapse”, “co-
caine addiction”, and “dopaminergic synapse” were also 
detected. These results not only confirm the potential cen- 
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Figure 4  Reconstructed gene map for eating disorder from protein-protein interaction data. The 53 genes in orange are genes from the core dataset in our 
EDdb. The remaining 25 genes in blue are linker genes that bridge the 53 genes. 
Table 2  Six significantly enriched signaling pathways of 78 genes in a reconstructed sub-network using PPI dataa) 
Pathway Source P-value* 
Neuroactive ligand-receptor interaction KEGG 2.09×10 
Serotonergic synapse KEGG 1.87×10 
Cocaine addiction KEGG 6.17×10 
Dopaminergic synapse KEGG 7.69×10 
Adipocytokine signaling pathway KEGG 1.05×10 
Visceral fat deposits and the metabolic syndrome BioCarta 3.52×10 
a) *, Corrected by Benjamin-Hochberg. 
tral role of adipocytokine signaling in eating disorder, but 
also provide more clues on signaling pathways related to 
other neurotransmitters. 
3  Discussion 
The high genetic heterogeneity of eating disorder poses an 
enormous challenge in understanding the disease etiology. 
Classical identification of candidate genes for complex dis-
orders has been conducted experimentally. However, these 
individual studies for identifying specific genes/variants 
predisposed to eating disorder from different technology 
platforms are seldom incorporated with known biological 
information such as common pathways between eating dis-
order and other metabolic and psychiatric disorders. Heter-
ogeneous data source integration might remove bias result-
ing from any single technology platform, and systems biol-
ogy approach could provide additional insight into the ge-
netic etiology not observed by any individual study [6164]. 
Our EDdb is a high-quality resource containing genetic data 
from association studies, linkage scans, gene expression, 
literature, Gene Ontology (GO) annotations, and metabolic 
and signaling pathways. Each confirmed gene in our core 
dataset is linked with highly referred citations. By integrat-
ing protein-protein interactions and related disease data, we 
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expanded the candidate genes for eating disorder to broader 
molecular networks.  
Our collection shows that 59 genes have been confirmed 
to be linked to eating disorder. Moreover, our systematic 
pathway and sub-network reconstruction revealed that the 
adipocytokine signaling pathway may be the central signal-
ing pathway in eating disorder. Combining the upstream 
signaling events in the BioCarta pathway of “visceral fat 
deposits and the metabolic syndrome” with the KEGG “ad-
ipocytokine signaling pathway”, we propose a key joint 
signaling map for weight regulation in eating disorder, 
which may serve as an interesting hypothesis for further 
experimental testing. For instance, from the upstream sig-
naling molecules of the “visceral fat deposits and the meta-
bolic syndrome” pathway, only HSD11B2 is in EXP3 with 
indirect evidence, while all the remaining seven genes have 
literature support. HSD11B2 is the enzyme that regulates 
the glucocorticoid metabolism. The interaction between 
glucocorticoid and insulin is a very important signal for 
regulating long-term energy metabolism [64]. In particular, 
NR3C1, the downstream gene of HSD11B2, has been re-
ported to be associated with glucocorticoid resistance, eat-
ing disorder and obesity [58,66]. Therefore, it is highly pos-
sible that HSD11B2 is related to eating disorder. Other 
highly potential genes include four genes (MTOR, JNK, IKK 
and PRKCQ), which are absent from EDdb. These genes 
form a connected module centered around PRKCQ in re-
sponse to the diacylglycerol signal and ensure cell survival 
and proliferation [67]. It has been reported that mouse 
Prkcq affects fat-induced insulin resistance and glucose 
transport [68], thus it is possible that the human PRKCQ is 
involved in insulin resistance and may also be involved in 
eating disorder. 
Comparison of pathway contents demonstrated that eat-
ing disorder is strongly associated with obesity, schizophre-
nia and bipolar disorder. All four upstream signals (TNF, 
LEP, LEPR and ADIPO) from our core dataset and EXP1 
dataset are shared with obesity, and five of the six down-
stream effector molecules are also shared with obesity. In 
our key signaling map, 25 of the 43 genes are associated 
with obesity. Such a high proportion of obesity-related 
genes in the map may provide clues for explaining some 
features of weight regulation in both diseases related to un-
healthy lifestyle.  
An interesting point to be emphasized is that the majority 
of the molecules in our proposed key signaling pathway are 
functional elements such as transcriptional regulators relat-
ed to neuronal and synaptic function or key enzymes in me-
tabolism. Therefore, the final pathway size underlying the 
etiology of eating disorder tends to be larger when more 
involved molecules are added. In summary, the level of 
complexity of the disorder stems from its functional com-
ponents such as transcriptional regulators and key enzymes.  
In conclusion, these analyses demonstrate that EDdb is a 
valuable tool for discovering potential candidate genes and 
pathways of eating disorder, as well as potential cross-talk 
between obesity and eating disorder. As a result of system-
atically collected and extended candidate genes, EDdb may 
also be helpful in explaining the underlying molecular 
mechanisms of eating disorder. 
4  Conclusion 
EDdb was constructed as a free database and analysis server 
to enable biochemists to quickly find summarized genes 
related to eating disorder. Our systematic pathway studies 
revealed that a key joint pathway combining the KEGG 
“adipocytokine signaling pathway” and the BioCarta path-
way of “visceral fat deposits and the metabolic syndrome” 
may be the central signaling pathway of weight regulation, 
linking eating disorder with other relevant diseases such as 
obesity. The EDdb database can be accessed at http://eddb. 
cbi.pku.edu.cn. 
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